Clinical Trial Update: Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring how belatacept modulates alloimmune and antiviral responses after kidney transplantation, with completed status and results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Renal Transplant Rejection | Phase 4 | Status: COMPLETED | Results posted: 2022-12-13